Folfox-Bevacizumab Chemotherapy In Patients With Progressive Metastatic Neuroendocrine Tumors

C. Lacombe,M. Perrier,O. Hentic, H. Brixi, V. Rebours,G. Cadiot,P. Ruszniewski,L. De Mestier

ANNALS OF ONCOLOGY（2021）

引用 1|浏览1

暂无评分

摘要

Well-differentiated neuroendocrine tumors (NETs) are relatively rare, highly vascularized neoplasms. Antiangiogenic drugs have shown efficacy in patients with advanced NETs, although the efficacy of FOLFOX-bevacizumab has been scarcely described in this setting. Hence, we aimed to report its efficacy and tolerance in patients with metastatic NETs.

查看译文

关键词

neuroendocrine tumor, antiangiogenic therapy, vegf, well-differentiated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要